Search Results - "Jabbar‐Lopez, Zarif K."

Patient Perspectives on Living With Severe Prurigo Nodularis by Rodriguez, Danielle, Kwatra, Shawn G, Dias-Barbosa, Carla, Zeng, Fanyang, Jabbar Lopez, Zarif K, Piketty, Christophe, Puelles, Jorge

“…Because of a paucity of qualitative research on prurigo nodularis (PN), the symptoms and impacts of PN that are most important to patients are poorly…”
Get more information

Epidemiology of prurigo nodularis in England: a retrospective database analysis by Morgan, Christopher Ll, Thomas, Melissa, Ständer, Sonja, Jabbar‐Lopez, Zarif K., Piketty, Christophe, Gabriel, Sylvie, Currie, Craig J., Puelles, Jorge

“…Background Prurigo nodularis is a debilitating skin condition that is classified as rare by the Genetic and Rare Diseases Information Center (GARD) and the…”
Get full text

The effect of water hardness on atopic eczema, skin barrier function: A systematic review, meta‐analysis by Jabbar‐Lopez, Zarif K., Ung, Chuin Ying, Alexander, Helen, Gurung, Nikeeta, Chalmers, Joanne, Danby, Simon, Cork, Michael J., Peacock, Janet L., Flohr, Carsten

“…Background Hard domestic water has been reported to worsen atopic eczema (AE) and may contribute to its development in early life. Objective To review the…”
Get full text

Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis by Kwatra, Shawn G., Yosipovitch, Gil, Legat, Franz J., Reich, Adam, Paul, Carle, Simon, Dagmar, Naldi, Luigi, Lynde, Charles, De Bruin-Weller, Marjolein S., Nahm, Walter K., Sauder, Maxwell, Gharib, Rola, Barbarot, Sebastien, Szepietowski, Jacek C., Conrad, Curdin, Fleischer, Alan, Laquer, Vivian T., Misery, Laurent, Serra-Baldrich, Esther, Lapeere, Hilde, Ahmad, Faiz, Jabbar Lopez, Zarif K., Piketty, Christophe, Ständer, Sonja

“…In this trial of 274 patients with prurigo nodularis, a debilitating neuroimmune skin disease, the interleukin-31 receptor antagonist nemolizumab significantly…”
Get full text

Assessing Response in Atopic Dermatitis: A Systematic Review of the Psychometric Performance of Measures Used in HTAs and Clinical Trials by Penton, Hannah, Jayade, Sayeli, Selveindran, Santhani, Heisen, Marieke, Piketty, Christophe, Ulianov, Liliana, Jabbar-Lopez, Zarif K., Silverberg, Jonathan I., Puelles, Jorge

“…Introduction Assessing treatment response is key to determining treatment value in atopic dermatitis (AD). Currently, response is assessed using various…”
Get full text

The Sleep Disturbance Numerical Rating Scale: Content Validity, Psychometric Validation, and Meaningful Within-Patient Change in Prurigo Nodularis by Ständer, Sonja, Fofana, Fatoumata, Dias-Barbosa, Carla, Rodriguez, Danielle, Budhiarso, Ismail, Jabbar-Lopez, Zarif K., Piketty, Christophe, Vernon, Margaret, Puelles, Jorge

“…Introduction Sleep is often disturbed in patients with prurigo nodularis (PN). To address the lack of validated patient-reported outcome (PRO) measures for…”
Get full text

Incident Comorbidity, Resource Use, and All-Cause Mortality Associated with Prurigo Nodularis: A United Kingdom Retrospective Database Analysis by Morgan, Christopher Ll, Thomas, Melissa, Heywood, Benjamin R., Ständer, Sonja, Kwatra, Shawn G., Jabbar-Lopez, Zarif K., Piketty, Christophe, Gabriel, Sylvie, Puelles, Jorge

“…We described comorbidity, resource utilization, and mortality for patients with prurigo nodularis (PN) using data from the Clinical Practice Research Datalink…”
Get full text

Novel systemic therapies in atopic dermatitis: what do we need to fulfil the promise of a treatment revolution? [version 1; peer review: 3 approved] by Alexander, Helen, Patton, Thomas, Jabbar-Lopez, Zarif K, Manca, Andrea, Flohr, Carsten

“…Patients with atopic dermatitis (AD) who do not adequately respond to topical therapy and phototherapy often need systemic immunomodulatory treatment to…”
Get full text

Protocol for an outcome assessor-blinded pilot randomised controlled trial of an ion-exchange water softener for the prevention of atopic eczema in neonates, with an embedded mechanistic study: the Softened Water for Eczema Prevention (SOFTER) trial by Jabbar-Lopez, Zarif K, Gurung, Nikeeta, Greenblatt, Danielle, Briley, Annette, Chalmers, Joanne R, Thomas, Kim Suzanne, Frost, Tony, Kezic, Sanja, Common, John E A, Kong, Heidi H, Segre, Julie A, Danby, Simon, Cork, Michael J, Peacock, Janet L, Flohr, Carsten

“…IntroductionAtopic eczema affects 20% of UK children, and environmental factors are important in its aetiology. Several observational studies suggest an…”
Get full text

Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis by Jabbar-Lopez, Zarif K., Yiu, Zenas Z.N., Ward, Victoria, Exton, Lesley S., Mohd Mustapa, M. Firouz, Samarasekera, Eleanor, Burden, A. David, Murphy, Ruth, Owen, Caroline M., Parslew, Richard, Venning, Vanessa, Warren, Richard B., Smith, Catherine H.

“…Multiple biologic treatments are licensed for psoriasis. The lack of head-to-head randomized controlled trials makes choosing between them difficult for…”
Get full text

Development and Validation of an Algorithm to Accurately Identify Atopic Eczema Patients in Primary Care Electronic Health Records from the UK by Abuabara, Katrina, Magyari, Alexa M., Hoffstad, Ole, Jabbar-Lopez, Zarif K., Smeeth, Liam, Williams, Hywel C., Gelfand, Joel M., Margolis, David J., Langan, Sinead M.

“…Electronic health records hold great promise for clinical and epidemiologic research. Undertaking atopic eczema (AE) research using such data is challenging…”
Get full text

Omalizumab, an Anti-IgE mAb, Receives Approval for the Treatment of Chronic Idiopathic/Spontaneous Urticaria by Wu, Keith C.P., Jabbar-Lopez, Zarif K.

“…Omalizumab, an anti-IgE mAb, has recently been approved by the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) for the treatment of…”
Get full text

Re: Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis by Jabbar-Lopez, Zarif K., Yiu, Zenas Z.N., Ward, Victoria, Exton, Lesley S., Mohd Mustapa, M. Firouz, Samarasekera, Eleanor, Burden, A. David, Murphy, Ruth, Owen, Caroline M., Parslew, Richard, Venning, Vanessa, Warren, Richard B., Smith, Catherine H.

Get full text

672 - Nemolizumab monotherapy improves itch, sleep disturbance, and skin lesions in patients with moderate-to-severe prurigo nodularis: Pooled analyses from OLYMPIA 1 and OLYMPIA 2 phase 3 studies by Yosipovitch, Gil, Ständer, Sonja, Metz, Martin, Pink, Andrew E, Silverberg, Jonathan I, Sofen, Howard, Ahmed, Faiz, Noda, Aliene, Jabbar Lopez, Zarif K, Piketty, Christophe, Kwatra, Shawn G

Get full text

673 - Efficacy of nemolizumab in different subgroups of patients with prurigo nodularis in two randomized, placebo-controlled phase 3 trials by Kwatra, Shawn G, Metz, Martin, Pink, Andrew E, Yosipovitch, Gil, Gharib, Rola, Sundaram, Hema, Chen, Xiaoxiao, Noda, Aliene, Jabbar Lopez, Zarif K, Piketty, Christophe, Ständer, Sonja

Get full text